Clinical trial
Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in…
NCT00003916 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003916 |
|---|---|
| Title | Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma |
| Official title | Focal Fractionated Conformal Stereotactic Boost Following Conventional Radiotherapy of High Grade Gliomas: A Randomized Phase III Study |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Radiation |
| Interventions | radiation therapy, stereotactic radiosurgery |
| Enrollment | 25 |
| Start date | Apr 1, 1999 |
| Primary completion | Dec 1, 2001 |
| First posted | Feb 16, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Australia, France, Germany, Netherlands, Spain, Switzerland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: